Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fidelio Capital in connection with the acquisition of Veterinary Orthopedic Implants, Inc.
Mandate

Vinge advises Fidelio Capital in connection with the acquisition of Veterinary Orthopedic Implants, Inc.

May 22, 2020 Banking and Finance M&A EU, Competition and Regulatory

Vinge has advised Fidelio Capital on the acquisition of Veterinary Orthopedic Implants, Inc (“VOI”).

VOI is a fast-growing US company within the market for veterinary orthopedic implants and instruments.

Vinge’s team consisted of, among others, Jonas Bergström, Manne Bergström, Johanna Wiberg and Carl-Fredrik Wachtmeister (M&A/Corporate), Albert Wållgren and Axel Jansson (Banking and Finance), Johan Karlsson, Sebastian Örndahl and Lisa Malmborg (Competition) and Christoffer Widström (VDR-specialist).

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025